Phathom Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/13/2026 | 12.47 M | $206.82 M | 0.00% | 16.99% |
| MEDICXI VENTURES MANAGEMENT (JERSEY) LTD | 01/23/2026 | 7.46 M | $123.84 M | 0.00% | 10.17% |
| INVESCO LTD. | 02/19/2026 | 3.92 M | $65.04 M | 1.44% | 5.34% |
| BLACKROCK, INC. | 02/12/2026 | 3.56 M | $58.99 M | 4.50% | 4.84% |
| CARLYLE GROUP INC. | 02/13/2026 | 3.50 M | $57.98 M | 0.00% | 4.76% |
| VANGUARD GROUP INC | 01/29/2026 | 3.18 M | $52.71 M | -1.19% | 4.33% |
| ENSIGN PEAK ADVISORS, INC | 02/12/2026 | 2.35 M | $39.02 M | -6.04% | 3.20% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 2.08 M | $34.54 M | -59.02% | 2.84% |
| NEA MANAGEMENT COMPANY, LLC | 02/17/2026 | 1.96 M | $32.52 M | 0.00% | 2.67% |
| 683 CAPITAL MANAGEMENT, LLC | 02/17/2026 | 1.79 M | $29.61 M | -1.94% | 2.43% |
| CATALYS PACIFIC, LLC | 02/10/2026 | 1.43 M | $23.71 M | 22.44% | 1.95% |
| WASATCH ADVISORS LP | 02/12/2026 | 1.33 M | $22.09 M | -13.37% | 1.81% |
| GW&K INVESTMENT MANAGEMENT, LLC | 02/11/2026 | 1.31 M | $21.68 M | 14.19% | 1.78% |
| STATE STREET CORP | 02/13/2026 | 1.15 M | $19.07 M | 9.11% | 1.57% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 1.07 M | $17.81 M | -1.42% | 1.46% |
| PROPEL BIO MANAGEMENT, LLC | 02/11/2026 | 740.92 K | $12.29 M | 34.00% | 1.01% |
| CATALIO CAPITAL MANAGEMENT, LP | 02/17/2026 | 699.00 K | $11.60 M | -38.06% | 0.95% |
| DIVISADERO STREET CAPITAL MANAGEMENT, LP | 02/17/2026 | 662.31 K | $10.99 M | 100.00% | 0.90% |
| MOORE CAPITAL MANAGEMENT, LP | 02/17/2026 | 600.00 K | $9.95 M | 0.00% | 0.82% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 549.17 K | $9.11 M | 255.96% | 0.75% |
| SUMMITTX CAPITAL, L.P. | 02/17/2026 | 517.82 K | $8.59 M | 34.16% | 0.71% |
| CAPTION MANAGEMENT, LLC | 02/17/2026 | 486.30 K | $8.07 M | -51.37% | 0.66% |
| STEPSTONE GROUP LP | 02/17/2026 | 422.09 K | $4.97 M | 0.00% | 0.58% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 397.91 K | $6.60 M | 8.75% | 0.54% |
| NEXT CENTURY GROWTH INVESTORS LLC | 02/13/2026 | 393.77 K | $6.53 M | 100.00% | 0.54% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 392.05 K | $6.50 M | 157.87% | 0.53% |
| JANE STREET GROUP, LLC | 02/12/2026 | 384.77 K | $6.38 M | 258.72% | 0.52% |
| NORTHERN TRUST CORP | 02/17/2026 | 356.47 K | $5.91 M | -0.31% | 0.49% |
| SIMPLIFY ASSET MANAGEMENT INC. | 02/09/2026 | 321.94 K | $5.34 M | 0.00% | 0.44% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 317.60 K | $5.27 M | 474.32% | 0.43% |
| CITADEL ADVISORS LLC | 02/17/2026 | 311.32 K | $5.16 M | -38.80% | 0.42% |
| UBS GROUP AG | 01/29/2026 | 304.38 K | $5.05 M | -10.04% | 0.41% |
| JPMORGAN CHASE & CO | 02/11/2026 | 296.68 K | $4.92 M | 116.64% | 0.40% |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | 02/17/2026 | 276.99 K | $4.60 M | 376.77% | 0.38% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 02/17/2026 | 267.96 K | $4.45 M | 0.00% | 0.37% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 261.07 K | $4.33 M | 100.00% | 0.36% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 259.00 K | $4.30 M | 3.98% | 0.35% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/17/2026 | 207.09 K | $3.44 M | -29.84% | 0.28% |
| AVIDITY PARTNERS MANAGEMENT LP | 02/13/2026 | 206.08 K | $3.42 M | -32.65% | 0.28% |
| NEWEDGE ADVISORS, LLC | 02/18/2026 | 200.82 K | $3.16 M | -0.35% | 0.27% |
| BIRCHVIEW CAPITAL, LP | 02/13/2026 | 195.00 K | $3.24 M | 129.41% | 0.27% |
| WOODLINE PARTNERS LP | 02/17/2026 | 187.29 K | $3.11 M | 0.00% | 0.26% |
| AMERIPRISE FINANCIAL INC | 02/17/2026 | 185.74 K | $3.08 M | -66.51% | 0.25% |
| CAXTON ASSOCIATES LLP | 02/13/2026 | 181.97 K | $3.02 M | 371.79% | 0.25% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 02/02/2026 | 147.00 K | $2.44 M | 100.00% | 0.20% |
| GILDER GAGNON HOWE & CO LLC | 02/17/2026 | 145.17 K | $2.41 M | 63.96% | 0.20% |
| TREXQUANT INVESTMENT LP | 02/17/2026 | 136.82 K | $2.27 M | 75.00% | 0.19% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 134.55 K | $2.23 M | -8.13% | 0.18% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 122.97 K | $2.04 M | -3.47% | 0.17% |
| MORGAN STANLEY | 02/13/2026 | 117.78 K | $1.95 M | -53.91% | 0.16% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Phathom Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 202 institutional investors and hedge funds held shares of Phathom Pharmaceuticals Inc. The most heavily invested institutionals were:
Medicxi Ventures Management (Jersey) Ltd: 7.46 M
WASATCH ADVISORS LP: 1.34 M
UBS Group AG: 360,371
Simplify Asset Management Inc.: 262,386
Bank of New York Mellon Corp: 124,018
Nuveen, LLC: 117,301
84.42% of Phathom Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 69.00 M shares in the last 24 months. This purchase volume represents approximately $766.63 M in transactions.